Lotte M C Jacobs

Ms. Lotte M C Jacobs

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2023 in International Journal of Surgery
Verified
Journal Article
Open access
GRGabby T.J.A. Reijnders-Boerboom
Gabby T.J.A. Reijnders-Boerboom
KAKim I. Albers
Kim I. Albers
LJLotte M C Jacobs
Lotte M C Jacobs
EHEsmee van Helden
Esmee van Helden
CRCamiel Rosman
Camiel Rosman
MWMichiel Warlé
Michiel Warlé
Background: Guidelines do not provide clear recommendations with regard to the use of low intra-abdominal pressure (IAP) during laparoscopic surgery. The aim of this meta-analysis is to assess the influence of low versus standard IAP during laparoscopic surgery on the key-outcomes in perioperative medicine as defined by the StEP-COMPAC consensus group. Materials and methods: We searched the Cochrane Library, PubMed, and EMBASE for randomized controlled trials comparing low IAP (<10 mmHg) with standard IAP (10 mmHg or higher) during laparoscopic surgery without time, language, or blinding restrictions. According to the PRISMA guidelines, two review authors independently identified trials and extracted data. Risk ratio (RR), and mean difference (MD), with 95% CIs were calculated using random-effects models with RevMan5. Main outcomes were based on StEP-COMPAC recommendations, and included postoperative complications, postoperative pain, postoperative nausea and vomiting (PONV) scores, and length of hospital stay. Results: Eighty-five studies in a wide range of laparoscopic procedures (7349 patients) were included in this meta-analysis. The available evidence indicates that the use of low IAP (<10 mmHg) leads to a lower incidence of mild (Clavien–Dindo grade 1–2) postoperative complications (RR=0.68, 95% CI: 0.53–0.86), lower pain scores (MD=−0.68, 95% CI: −0.82 to 0.54) and PONV incidence (RR=0.67, 95% CI: 0.51–0.88), and a reduced length of hospital stay (MD=−0.29, 95% CI: −0.46 to 0.11). Low IAP did not increase the risk of intraoperative complications (RR=1.15, 95% CI: 0.77–1.73). Conclusions: Given the established safety and the reduced incidence of mild postoperative complications, lower pain scores, reduced incidence of PONV, and shorter length of stay, the available evidence supports a moderate to strong recommendation (1a level of evidence) in favor of low IAP during laparoscopic surgery.

10 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
LWLoes Willems
Loes Willems
LJLotte M C Jacobs
Lotte M C Jacobs
LGLaszlo A. Groh
Laszlo A. Groh
HCHugo Ten Cate
Hugo Ten Cate
HSHenri M.H. Spronk
Henri M.H. Spronk
MWMichiel Warlé
Michiel Warlé
Introduction: Among its effect on virtually all other organs, COVID-19 affects the cardiovascular system, potentially jeopardizing the cardiovascular health of millions. Previous research has shown no indication of macrovascular dysfunction as reflected by carotid artery reactivity, but has shown sustained microvascular dysfunction, systemic inflammation, and coagulation activation at 3 months after acute COVID-19. The long-term effects of COVID-19 on vascular function remain unknown. Materials and Methods: This cohort study involved 167 patients who participated in the COVAS trial. At 3 months and 18 months after acute COVID-19, macrovascular dysfunction was evaluated by measuring the carotid artery diameter in response to cold pressor testing. Additionally, plasma endothelin-1, von Willebrand factor, Interleukin(IL)-1ra, IL-6, IL-18, and coagulation factor complexes were measured using ELISA techniques. Results: The prevalence of macrovascular dysfunction did not differ between 3 months (14.5%) and 18 months (11.7%) after COVID-19 infection (p = 0.585). However, there was a significant decrease in absolute carotid artery diameter change, 3.5% ± 4.7 vs. 2.7% ± 2.5, p—0.001, respectively. Additionally, levels of vWF:Ag were persistently high in 80% of COVID-19 survivors, reflecting endothelial cell damage and possibly attenuated endothelial function. Furthermore, while levels of the inflammatory cytokines interleukin(IL)-1RA and IL-18 were normalized and evidence of contact pathway activation was no longer present, the concentrations of IL-6 and thrombin:antithrombin complexes were further increased at 18 months versus 3 months (2.5 pg/mL ± 2.6 vs. 4.0 pg/mL ± 4.6, p = 0.006 and 4.9 μg/L ± 4.4 vs. 18.2 μg/L ± 11.4, p < 0.001, respectively). Discussion: This study shows that 18 months after COVID-19 infection, the incidence of macrovascular dysfunction as defined by a constrictive response during carotid artery reactivity testing is not increased. Nonetheless, plasma biomarkers indicate sustained endothelial cell activation (vWF), systemic inflammation (IL-6), and extrinsic/common pathway coagulation activation (FVII:AT, TAT) 18 months after COVID-19 infection.

24 May 2024 in BJU International
Verified
Journal Article
Open access
GRGabby T. J. A. Reijnders‐Boerboom
Gabby T. J. A. Reijnders‐Boerboom
LJLotte M C Jacobs
Lotte M C Jacobs
LHLeonie S. Helder
Leonie S. Helder
IPIvo F. Panhuizen
Ivo F. Panhuizen
MBMaik P. J. Brouwer
Maik P. J. Brouwer
MWMichiel C. Warlé
Michiel C. Warlé
Objective: To compare the effectiveness of low intra‐abdominal pressure (IAP) facilitated by deep neuromuscular block (NMB) to standard practice in improving the quality of recovery, preserving immune function, and enhancing parietal perfusion during robot‐assisted radical prostatectomy (RARP). Patients and Methods: In this blinded, randomised controlled trial, 96 patients were randomised to the experimental group with low IAP (8 mmHg) facilitated by deep NMB (post‐tetanic count 1–2) or the control group with standard IAP (14 mmHg) and moderate NMB (train‐of‐four 1–2). Recovery was measured using the 40‐item Quality of Recovery questionnaire and 36‐item Short‐Form Health survey. Immune function was evaluated by plasma damage‐associated molecular patterns, cytokines, and ex vivo lipopolysaccharide‐stimulated cytokine production. Parietal peritoneum perfusion was measured by analysing the recordings of indocyanine‐green injection. Results: Quality of recovery was not superior in the experimental group ( n = 46) compared to the control group ( n = 50). All clinical outcomes, including pain scores, postoperative nausea and vomiting, and hospital stay were similar. There were no significant differences in postoperative plasma concentrations of damage‐associated molecular patterns, cytokines, and ex vivo cytokine production capacity. The use of low IAP resulted in better parietal peritoneum perfusion. Conclusion: Despite better perfusion of the parietal peritoneum, low IAP facilitated by deep NMB did not improve the quality of recovery or preserve immune function compared to standard practice in patients undergoing RARP.

7 January 2025 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
LJLotte M C Jacobs
Lotte M C Jacobs
VBVeerle Bijkerk
Veerle Bijkerk
LELucas T. van Eijk
Lucas T. van Eijk
LJLeo A. B. Joosten
Leo A. B. Joosten
CKChristiaan Keijzer
Christiaan Keijzer
MWMichiel C. Warlé
Michiel C. Warlé
Increasing evidence shows that postoperative innate immune dysregulation is associated with delayed recovery and infectious complications. The aim of this study was to compare the effects of general versus spinal anesthesia on innate immune function during and after total hip arthroplasty (THA). This comparative matched cohort study used data from two single-center randomized-controlled trials. Patients from the control group of the HIPPO study received general anesthesia and were matched to control patients from the MAGIC study who received spinal anesthesia in a 2:1 ratio (general(n = 18); spinal(n = 9)). Immune function was assessed by determination of ex vivo cytokine production capacity upon whole blood stimulation with E. coli lipopolysaccharides (LPS) and measurement of plasma cytokines and danger-associated molecular patterns (DAMPs). In the general anesthesia group, ex vivo cytokine production capacity of IL-1β was significantly lower shortly after induction (p = 0.02) and both IL-1β and IL-6 were significantly lower at the end of surgery compared to the spinal anesthesia group (p = 0.002 and p = 0.02, respectively). On postoperative day 1 (POD1), no differences were observed. Plasma cytokine concentrations did not differ between the spinal and general anesthesia group at most timepoints, except for IL-10 at the end of surgery (p = 0.04) and TNF on POD1 (p = 0.04), which were higher in the general anesthesia group. Plasma concentrations of DAMPs did not differ between the groups. General anesthesia has a transient impact on innate immune function in patients undergoing THA, but the clinical significance of anesthesia-induced innate immune dysregulation might be limited as no differences were observed on POD1. The HIPPO study (NCT05562999, date of registration 2022-10-03) and MAGIC study (NCT05723406, date of registration 2023-02-10) are registered at ClinicalTrials.gov.

20 February 2026 in International Journal of Surgery
Verified
Journal Article
Open access
LJLotte M C Jacobs
Lotte M C Jacobs
VBVeerle Bijkerk
Veerle Bijkerk
KAKim I. Albers-Warlé
Kim I. Albers-Warlé
GRGabby T.J.A. Reijnders-Boerboom
Gabby T.J.A. Reijnders-Boerboom
LDLuuk D. Drager
Luuk D. Drager
MWMichiel C. Warlé
Michiel C. Warlé
Background: Major surgery elicits a complex immune response involving both systemic inflammation and innate immune suppression. These changes may contribute to postoperative infectious complications. This study aimed to determine whether perioperative immune activation and suppression patterns are associated with the development of postoperative infectious complications. Materials and methods: A pooled analysis of six prospective clinical studies was conducted to evaluate perioperative immune function in patients undergoing diverse surgical procedures. Immune monitoring included plasma danger-associated molecular pattern and cytokine concentrations, ex vivo cytokine production after lipopolysaccharide stimulation of whole blood, and proteomic profiling. Clinical outcomes included postoperative infections, pain scores, and quality of recovery. Results: A total of 487 patients were included. Danger-associated molecular patterns generally increased following surgery. All surgical procedures induced a stereotypical immune trajectory, characterized by early plasma interleukin (IL)-6 and IL-10 elevation and suppression of ex vivo tumor necrosis factor (TNF) and IL-1β production, most pronounced on postoperative day 1. Immune suppression persisted through POD3 in patients undergoing colorectal surgery, but resolved more quickly after breast surgery, a less invasive procedure. Patients who developed post-operative infections had higher plasma IL-6 and TNF concentrations on postoperative day 1 and attenuated ex vivo TNF production on postoperative day 3. Proteomic profiling confirmed IL-6 upregulation and identified consistent downregulation of multiple immune signaling proteins, including IFN-γ and chemokines involved in lymphocyte activation. Conclusion: Surgical injury initiates a coordinated immune response with early inflammation and delayed innate immune suppression. Failure to recover innate immune function by postoperative day 3 is associated with increased infection risk. Perioperative immune profiling may enable early risk stratification and inform targeted immunomodulatory strategies.

17 October 2025 in Quality of Life Research
Verified
Journal Article
Open access
PDF file
MGMarcela M. Suazo Guevara
Marcela M. Suazo Guevara
SWSophie F. Waardenburg
Sophie F. Waardenburg
DKDorthe Odyl Klein
Dorthe Odyl Klein
GBGJ Bonsel
GJ Bonsel
EBErwin Birnie
Erwin Birnie
SKSander M. J. van Kuijk
Sander M. J. van Kuijk
Purpose: Post COVID-19 Condition (PCC) negatively impacts Health Related Quality of Life (HRQoL) and can persist for years after initial infection. This study examined long term HRQoL of COVID-19 survivors with PCC to explore whether and how HRQoL changes over time, and to determine which patient characteristics are associated with changes. Methods: COVID-19 survivors from the Dutch CORona Follow-Up (CORFU) study were prospectively followed for up to 3 years post-infection using self-report questionnaires. PCC was defined on presence of symptoms reported at the 2-year time point. Within-person change in EQ-5D-5L utility and EQ VAS scores were analyzed from the 2-year to the 3-year time point. Changes were described using summary statistics, and associations with patient characteristics were analyzed using multivariable linear regressions. Results: Among 158 participants that met PCC definition 2-years after infection, mean utility and EQ VAS change score was 0.01 (95%CI − 0.02,0.04), and 0.9 (95%CI − 1.6,3.4), respectively. Based on EQ utility change scores, 30% experienced a decrease, 32% an increase, and 37% no change. Similar distributions were observed for EQ VAS. Female sex was associated with decreasing utility scores. Increasing utility scores were associated with female sex of older age when compared to younger ones, and with people that initially reported social participation problems.. Conclusion: Individual changes in HRQoL within a year vary widely in the PCC population. Our findings suggest that certain subgroups of individuals with PCC are more vulnerable to prolonged declines in HRQoL.